Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PIKE HEALTH SERVICES, INC

NPI: 1720018971 · WAVERLY, OH 45690 · Family Medicine Physician · NPI assigned 07/04/2006

$9.12M
Total Medicaid Paid
286,353
Total Claims
219,268
Beneficiaries
182
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCRAFT, JEFFREY (VICE PRESIDENT FOR SYSTEM FINANCE)
NPI Enumeration Date07/04/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 30,205 $729K
2019 27,911 $692K
2020 25,628 $758K
2021 29,077 $999K
2022 34,568 $1.11M
2023 84,248 $2.17M
2024 54,716 $2.66M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 18,394 17,152 $2.04M
99284 8,728 7,548 $983K
99282 6,279 5,691 $695K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8,796 6,759 $648K
74176 2,470 2,015 $579K
99285 5,236 3,863 $527K
99214 7,723 6,543 $477K
99212 5,048 4,632 $430K
70450 1,866 1,451 $369K
99281 2,417 2,193 $293K
97530 2,783 789 $236K
92507 1,919 639 $153K
74177 549 410 $137K
96365 1,404 925 $128K
96361 446 273 $104K
96366 521 271 $93K
G0378 Hospital observation service, per hour 3,093 1,039 $87K
94640 1,163 815 $82K
80048 12,609 9,785 $67K
99213 1,137 870 $58K
93306 256 212 $54K
80053 9,318 7,354 $52K
72148 252 218 $50K
71275 251 170 $49K
20611 131 119 $37K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 582 474 $37K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,356 1,255 $37K
76705 355 297 $37K
80307 2,517 2,067 $37K
73721 132 124 $35K
85025 22,400 17,378 $35K
71250 463 366 $35K
87502 1,417 1,151 $31K
93005 8,728 7,015 $24K
84484 7,619 5,368 $20K
36415 27,690 20,317 $20K
71045 7,725 6,374 $20K
71046 705 595 $17K
96372 4,014 2,849 $15K
84443 1,739 1,440 $14K
80061 1,842 1,562 $14K
94060 102 90 $13K
Q3014 Telehealth originating site facility fee 1,144 1,027 $11K
83036 2,478 2,044 $11K
73630 434 345 $10K
82306 643 556 $10K
97110 141 58 $10K
72125 234 186 $8K
90686 764 642 $7K
64493 14 12 $7K
J3490 Unclassified drugs 1,065 634 $6K
80076 1,986 1,814 $6K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,634 1,440 $6K
62323 12 12 $6K
73562 109 100 $6K
73610 272 216 $5K
83880 2,136 1,574 $5K
81001 7,775 6,487 $5K
72020 705 658 $5K
73130 282 232 $4K
85610 4,778 3,772 $4K
82607 380 334 $4K
73030 202 161 $4K
87088 2,319 1,706 $4K
83605 3,379 2,341 $4K
87040 2,728 1,204 $4K
72100 141 117 $4K
90471 865 728 $4K
96374 4,095 3,216 $4K
70551 15 12 $3K
83735 2,795 1,909 $3K
85027 877 462 $3K
J7030 Infusion, normal saline solution , 1000 cc 1,948 1,364 $3K
94729 41 40 $3K
96375 2,656 1,744 $3K
11721 126 122 $3K
94726 49 41 $3K
87804 1,331 734 $3K
83540 426 357 $2K
87086 1,624 1,487 $2K
82947 1,551 466 $2K
85730 3,164 2,586 $2K
11719 165 159 $2K
87811 1,602 1,384 $2K
85379 1,506 1,237 $2K
84703 1,370 1,060 $2K
82077 866 647 $2K
82948 2,033 806 $2K
96367 84 54 $2K
82248 2,019 1,518 $2K
83690 2,603 1,999 $1K
90715 104 88 $1K
82803 1,172 682 $1K
82565 147 117 $1K
82140 418 300 $1K
87880 726 611 $1K
81003 1,559 1,267 $1K
96376 715 355 $1K
73560 118 92 $1K
80143 498 376 $1K
76536 12 12 $962.38
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 987 671 $877.25
J1885 Injection, ketorolac tromethamine, per 15 mg 2,319 1,807 $851.25
80179 473 363 $851.00
86140 123 66 $746.70
97162 16 14 $712.11
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,564 1,000 $671.62
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 89 50 $628.03
82550 384 281 $610.37
82570 92 72 $589.60
73502 36 27 $532.11
87186 815 502 $502.06
87635 44 40 $481.89
94761 786 620 $478.28
83525 84 57 $460.38
90656 56 49 $434.07
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,020 864 $432.72
73590 18 12 $411.36
82150 837 689 $401.04
87420 216 186 $400.89
87081 115 95 $344.93
82962 822 656 $323.69
74018 19 15 $312.29
J0696 Injection, ceftriaxone sodium, per 250 mg 780 417 $272.77
94760 437 351 $261.09
84100 225 196 $239.04
87426 215 147 $229.85
85652 92 58 $217.94
84439 15 12 $216.93
87633 14 12 $199.64
84466 56 47 $178.35
J1170 Injection, hydromorphone, up to 4 mg 423 247 $164.56
73110 12 12 $133.08
87280 78 60 $129.86
81025 169 162 $125.86
82728 57 47 $122.39
87400 125 114 $116.06
90460 26 26 $113.24
87077 43 33 $87.04
J0780 Injection, prochlorperazine, up to 10 mg 389 278 $83.34
80320 13 13 $82.52
84156 15 12 $71.70
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 128 102 $71.28
74022 41 38 $69.44
87581 14 12 $67.10
J1030 Injection, methylprednisolone acetate, 40 mg 52 51 $65.06
36600 128 62 $64.73
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 129 61 $55.92
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 38 18 $55.26
82746 48 42 $54.25
87430 59 57 $49.74
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 209 168 $47.40
J1100 Injection, dexamethasone sodium phosphate, 1 mg 336 241 $44.00
87486 14 12 $33.55
87798 14 12 $33.55
51702 14 12 $29.20
90732 13 13 $27.30
J2060 Injection, lorazepam, 2 mg 132 87 $19.87
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 266 169 $16.77
C9113 Injection, pantoprazole sodium, per vial 19 12 $16.51
J7050 Infusion, normal saline solution, 250 cc 167 102 $13.71
J1200 Injection, diphenhydramine hcl, up to 50 mg 186 107 $12.42
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 615 415 $11.70
J2919 Injection, methylprednisolone sodium succinate, 5 mg 53 48 $11.56
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 14 14 $8.40
J2270 Injection, morphine sulfate, up to 10 mg 24 12 $7.75
84132 39 12 $6.35
J3010 Injection, fentanyl citrate, 0.1 mg 33 14 $2.49
88175 14 12 $2.40
J7060 5% dextrose/water (500 ml = 1 unit) 67 26 $2.17
J2765 Injection, metoclopramide hcl, up to 10 mg 14 12 $0.91
64494 14 12 $0.00
J0456 Injection, azithromycin, 500 mg 14 12 $0.00
A9270 Non-covered item or service 1,027 47 $0.00
G0008 Administration of influenza virus vaccine 313 230 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 79 68 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 28 23 $0.00
J2704 Injection, propofol, 10 mg 17 12 $0.00
J1940 Injection, furosemide, up to 20 mg 29 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 554 311 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 42 41 $0.00
99218 47 15 $0.00